Bortezomib inhibits the survival and proliferation of bone marrow stromal cells

BACKGROUND: Bortezomib is widely used for the treatment of multiple myeloma. Bone marrow stromal cells (BMSCs) endow myeloma cells with survival and growth advantages. However, the influence of bortezomib on BMSCs is not well elucidated. We examined the effects of bortezomib on the survival and grow...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ha-Yon, Moon, Ji-Young, Ryu, Haewon, Choi, Yoon-Seok, Song, Ik-Chan, Lee, Hyo-Jin, Yun, Hwan-Jung, Kim, Samyong, Jo, Deog-Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486164/
https://www.ncbi.nlm.nih.gov/pubmed/26157778
http://dx.doi.org/10.5045/br.2015.50.2.87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486164/
https://www.ncbi.nlm.nih.gov/pubmed/26157778
http://dx.doi.org/10.5045/br.2015.50.2.87

Ejemplares similares